Table of Contents

1 Study Coverage

• 1.1 Insulin Pen Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Insulin Pen Market Size Growth Rate by Product
  • 1.4.2 Reusable Insulin Pen
  • 1.4.3 Disposable Insulin Pen
• 1.5 Market by End User
  • 1.5.1 Global Insulin Pen Market Size Growth Rate by End User
  • 1.5.2 Hospitals
  • 1.5.3 Clinics
  • 1.5.4 The Chemist's Shops
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Insulin Pen Market Size
  • 2.1.1 Global Insulin Pen Revenue 2014-2025
  • 2.1.2 Global Insulin Pen Sales 2014-2025
• 2.2 Insulin Pen Growth Rate by Regions
  • 2.2.1 Global Insulin Pen Sales by Regions
  • 2.2.2 Global Insulin Pen Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Insulin Pen Sales by Manufacturers
  • 3.1.1 Insulin Pen Sales by Manufacturers
  • 3.1.2 Insulin Pen Sales Market Share by Manufacturers
  • 3.1.3 Global Insulin Pen Market Concentration Ratio (CR5 and HHI)
• 3.2 Insulin Pen Revenue by Manufacturers
  • 3.2.1 Insulin Pen Revenue by Manufacturers (2014-2019)
  • 3.2.2 Insulin Pen Revenue Share by Manufacturers (2014-2019)
• 3.3 Insulin Pen Price by Manufacturers
• 3.4 Insulin Pen Manufacturing Base Distribution, Product Types
  • 3.4.1 Insulin Pen Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Insulin Pen Product Type
  • 3.4.3 Date of International Manufacturers Enter into Insulin Pen Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Insulin Pen Sales by Product
• 4.2 Global Insulin Pen Revenue by Product
• 4.3 Insulin Pen Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Insulin Pen Breakdown Data by End User

6 North America

• 6.1 North America Insulin Pen by Countries
  • 6.1.1 North America Insulin Pen Sales by Countries
  • 6.1.2 North America Insulin Pen Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Insulin Pen by Product
• 6.3 North America Insulin Pen by End User

7 Europe

• 7.1 Europe Insulin Pen by Countries
  • 7.1.1 Europe Insulin Pen Sales by Countries
  • 7.1.2 Europe Insulin Pen Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Insulin Pen by Product
• 7.3 Europe Insulin Pen by End User

8 Asia Pacific

• 8.1 Asia Pacific Insulin Pen by Countries
  • 8.1.1 Asia Pacific Insulin Pen Sales by Countries
  • 8.1.2 Asia Pacific Insulin Pen Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Insulin Pen by Product
• 8.3 Asia Pacific Insulin Pen by End User

9 Central & South America

• 9.1 Central & South America Insulin Pen by Countries
  • 9.1.1 Central & South America Insulin Pen Sales by Countries
  • 9.1.2 Central & South America Insulin Pen Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Insulin Pen by Product
• 9.3 Central & South America Insulin Pen by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Insulin Pen by Countries
  • 10.1.1 Middle East and Africa Insulin Pen Sales by Countries
  • 10.1.2 Middle East and Africa Insulin Pen Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Insulin Pen by Product
• 10.3 Middle East and Africa Insulin Pen by End User

11 Company Profiles

• 11.1 Novo Nordisk
  • 11.1.1 Novo Nordisk Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Novo Nordisk Insulin Pen Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Novo Nordisk Insulin Pen Products Offered
  • 11.1.5 Novo Nordisk Recent Development
• 11.2 Sanofi-Aventis
  • 11.2.1 Sanofi-Aventis Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Sanofi-Aventis Insulin Pen Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Sanofi-Aventis Insulin Pen Products Offered
  • 11.2.5 Sanofi-Aventis Recent Development
• 11.3 Eli Lilly
  • 11.3.1 Eli Lilly Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Eli Lilly Insulin Pen Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Eli Lilly Insulin Pen Products Offered
  • 11.3.5 Eli Lilly Recent Development
• 11.4 OWEN Mumford
  • 11.4.1 OWEN Mumford Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 OWEN Mumford Insulin Pen Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 OWEN Mumford Insulin Pen Products Offered
  • 11.4.5 OWEN Mumford Recent Development
• 11.5 WOCKHARDT
  • 11.5.1 WOCKHARDT Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 WOCKHARDT Insulin Pen Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 WOCKHARDT Insulin Pen Products Offered
  • 11.5.5 WOCKHARDT Recent Development
• 11.6 Dongbao(YPSOMED)
  • 11.6.1 Dongbao(YPSOMED) Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Dongbao(YPSOMED) Insulin Pen Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Dongbao(YPSOMED) Insulin Pen Products Offered
  • 11.6.5 Dongbao(YPSOMED) Recent Development
• 11.7 Gan & Lee
  • 11.7.1 Gan & Lee Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Gan & Lee Insulin Pen Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Gan & Lee Insulin Pen Products Offered
  • 11.7.5 Gan & Lee Recent Development

12 Future Forecast

• 12.1 Insulin Pen Market Forecast by Regions
  • 12.1.1 Global Insulin Pen Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Insulin Pen Revenue Forecast by Regions 2019-2025
• 12.2 Insulin Pen Market Forecast by Product
  • 12.2.1 Global Insulin Pen Sales Forecast by Product 2019-2025
  • 12.2.2 Global Insulin Pen Revenue Forecast by Product 2019-2025
• 12.3 Insulin Pen Market Forecast by End User
• 12.4 North America Insulin Pen Forecast
• 12.5 Europe Insulin Pen Forecast
• 12.6 Asia Pacific Insulin Pen Forecast
• 12.7 Central & South America Insulin Pen Forecast
• 12.8 Middle East and Africa Insulin Pen Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Insulin Pen Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Insulin Pen is a kind of insulin injection device, slightly larger in size than the pen, insulin refill in the pen. It’s easy to carry at users’ ease. The way to function is to fit with specific refill filled with insulin, fix the needle and pull off the needle cover. The operation is very convenient.

Insulin pen prevents the patient from the cumbersome procedure of extraction with a syringe from the insulin bottle; reduce embarrassment in public; supply convenience for poor vision and even blindness sufferers.

Global Insulin Pen demand is expected to reach about 660 Million Units by 2015, with estimated market revenue of 8000 million USD in the same year. The global consumption rate is about 15.36%.
Insulin Pen used to inject insulin. Insulin Pen has positive effects on skin than traditional injection device. It suggests that decreases rate of skin damage.
In global, about 70% production is consumed by US and EU. USA and EU are the main consumption regions. But in China has good prospects.
The global Insulin Pen market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Insulin Pen market based on company, product type, end user and key regions.

This report studies the global market size of Insulin Pen in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Insulin Pen in these regions.
This research report categorizes the global Insulin Pen market by top players/brands, region, type and end user. This report also studies the global Insulin Pen market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novo Nordisk
Sanofi-Aventis
Eli Lilly
OWEN Mumford
WOCKHARDT
Dongbao(YPSOMED)
Gan & Lee

Market size by Product
Reusable Insulin Pen
Disposable Insulin Pen
Market size by End User
Hospitals
Clinics
The Chemist's Shops

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Insulin Pen market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Insulin Pen market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Insulin Pen companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Insulin Pen submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Insulin Pen are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Insulin Pen market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.